Ventas, Inc.

Ventas, Inc. (VTR) Market Cap

Ventas, Inc. has a market capitalization of $39.68B.

Price: $81.61

-0.54 (-0.66%)

Market Cap: 39.68B

NYSE · time unavailable

CEO: Debra A. Cafaro

Sector: Real Estate

Industry: REIT - Healthcare Facilities

IPO Date: 1997-05-05

Website: https://www.ventasreit.com

Ventas, Inc. (VTR) - Company Information

Market Cap: 39.68B|Sector: Real Estate

Company Profile

As an S&P 500 company, Ventas operates strategically at the nexus of the dynamic healthcare and real estate industries. We stand as one of the world's foremost Real Estate Investment Trusts (REITs), utilizing financial capital to unlock property value. Our partnerships extend to leading care providers, developers, research and medical institutions, innovators, and healthcare organizations, all of whom benefit from the significant demographic trend of an aging population. For over two decades, Ventas has pursued a steadfast and effective strategy: maintaining a high-quality, diverse portfolio of assets and varied capital streams to skillfully navigate market fluctuations. A dedicated and experienced team collaborates with industry-leading partners to generate consistent, increasing cash flows and superior returns on a strong balance sheet, ultimately enriching Ventas's shareholders. As of September 30, 2020, Ventas either owned outright or managed through unconsolidated joint ventures approximately 1,200 properties.

Analyst Sentiment

79%
Strong Buy

From 21 Active Polls

1Y Forecast: $95.86

▲ +17.5% Potential Upside

Consensus Target Metrics

Low Bound

$88

Median

$95

High Bound

$110

Average

$96

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$95.86
▲ +17.46% Upside
Low Target
$88.00
8% Risk
Median Target
$95.00
16% Mid
High Target
$110.00
35% Max
Consensus
Buy
19 / 32 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Period EndingTrailing 12MMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024
Market Cap ($M)39,67638,94236,45731,91828,58130,25024,82226,58820,764
Enterprise Value ($M)52,21951,48548,93544,51741,24042,98937,66539,36833,595
Price to Earnings Ratio (P/E)149.22174.12129.83120.81104.67161.36109.18345.43267.76
Price/Earnings-to-Growth Ratio (PEG)29.9925.1025.2122.6329.2426.60117.413013.93
Price to Sales Ratio (P/S)6.4723.5023.2821.4420.1122.2719.2921.5117.29
Price to Book Ratio (P/B)2.962.972.912.582.482.642.302.722.16
Price to Free Cash Flow Ratio (P/FCF)83.10-67.5099.16111.4471.40115.3585.0493.5978.85
Enterprise Value to Sales (EV/Sales)31.0731.2529.9029.0231.6529.2631.8427.97
Enterprise Value to EBITDA (EV/EBITDA)21.2970.5187.9275.9671.1083.3080.8880.9763.92
Debt to Equity Ratio5.110.971.061.031.151.131.281.421.39

VTR Growth Runway Model

Standard long term linear growth fade

Multi-Stage Discounted Cash Flow Sandbox

Market Price$81.61
Intrinsic Value$100.24
Market Alignment
Undervalued by 22.8%relative to calculated intrinsic value
9.00%
Exp: 11%11%
i

Growth runway slowdown

This value provides a time window for the growth rate to decline beyond Stage 1 toward the terminal rate. Longer windows are most useful for companies with high growth starting conditions or strong competitive advantages. This option stretches out the growth rate slowdown across 5, 10, or 15-year steps. A high-growth starting condition (exceeding a 25% initial growth rate) automatically applies a curve decay to simulate realistic, rapid market saturation.
i

Terminal growth rate

With long-term inflation between 3-5%, revenue must grow by that baseline to maintain flat real-world market share. This value sets the permanent terminal growth rate to factor into the valuation beyond the growth slowdown runway toward maturity.

3-Stage Financial Runway Horizon

🧠 Perpetuity Horizon Engine (Stage 3: Post-2035)

Terminal FCF Base$4.84B
Perpetuity TV Value$91.16B
Discounted TV (PV)$38.51B
TV Weighting %63.6%
⚠️
Financial Model Disclaimer & Risk Disclosure: This interactive scenario simulator is an educational sandbox provided strictly for informational and analytical research purposes. Core historical financial statements and consensus estimates are sourced directly via Financial Modeling Prep (FMP). All downstream outputs are entirely deterministic, hypothetical projections generated by combining automated mathematical formulas (including linear interpolation and Gaussian bell-curve decay models) with user-selected variables and third-party financial data inputs. Users assume all liability for trading decisions executed based on these sandbox calculations.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 VENTAS REIT INC (VTR) — Investment Overview

🧩 Business Model Overview

Ventas is a healthcare real estate REIT that monetizes long-lived, institutionally managed properties leased to healthcare operators and used by patients and clinicians. The value chain is straightforward: (1) acquire/develop healthcare real estate (primarily senior housing and medical office buildings), (2) lease properties under contractual terms to experienced operators, and (3) manage the asset base to sustain occupancy, control operating costs, and maintain property condition.

Customer stickiness comes from the operational reality of healthcare facilities: operators cannot easily relocate patient flow, staff, referral patterns, regulatory licensing, and building-specific clinical workflows. Lease structures (including renewal options and ongoing maintenance requirements) typically create continuity of cash flows and reduce turnover risk relative to more discretionary real estate segments.

💰 Revenue Streams & Monetisation Model

Revenue is generated primarily through recurring rental income, typically structured as fixed rent with adjustments tied to escalators and/or revenue/expense mechanics embedded in lease agreements. In senior housing, income is generally less like “pure rent” in practice because operating performance can influence renewal dynamics, capital needs, and lease negotiations; however, the underlying monetisation remains anchored in long-duration contracts and property-level cash generation.

Margin drivers tend to be:

  • Same-property net operating income (NOI) resilience through occupancy stability, rent escalators, and controllable operating expenses.
  • Capital discipline—maintenance capex and redevelopment activity tied to long-term demand and competitive positioning.
  • Lease economics, where amortizing tenant risk is influenced by lease terms, operator quality, and renewal behavior.

🧠 Competitive Advantages & Market Positioning

Ventas’ positioning is anchored in healthcare-specific real estate scale, operating knowledge, and tenant/asset selectivity rather than property “brand” or retail foot traffic. The moat is best characterized as durable contractual cash flows plus execution capability in a regulated, operationally intensive asset class.

Primary moat (hard-to-replicate):

  • Integrated tenant/operator ecosystem (lease-backed operational stickiness): Healthcare providers and operators face high practical switching costs—building layout, clinical workflow fit, referral networks, and staffing continuity. These factors make redeployment of patients and services difficult without time and cost.
  • Scale and acquisition/development learning: Greater underwriting depth improves site selection, tenant screening, and redevelopment sequencing, supporting steadier occupancy and risk-adjusted returns.
  • Healthcare regulatory and compliance competence: Ongoing compliance expectations (licenses, inspections, safety standards) raise the operational barrier for new entrants that lack established processes.

Competitive benchmarking (examples):

  • Welltower (WELL): Strong senior housing and post-acute exposure, with a different mix across senior living categories and operator partnerships.
  • Healthpeak (PEAK): More concentrated in medical office assets, with emphasis on physician demand drivers and campus/health-system relationships.
  • Omega Healthcare Investors (OHI): Greater emphasis on skilled nursing facilities and related operator dynamics, often with different lease structures and portfolio risk profiles.

Compared with these peers, Ventas’ differentiation is the balanced healthcare real estate footprint across senior housing and medical office, supported by tenant-focused underwriting and an execution framework tailored to facilities where operational fit and compliance matter.

🚀 Multi-Year Growth Drivers

The investment case is underpinned by secular demand for healthcare real estate, with additional growth potential from portfolio optimization and prudent redevelopment.

  • Demographic tailwinds: Aging populations support long-duration demand for senior housing and care delivery infrastructure.
  • Healthcare service intensity: Ongoing utilization of outpatient and physician services supports demand for well-located medical office space.
  • Supply discipline and replacement cycles: Healthcare facility development is slower and more complex than generic real estate, enabling disciplined operators/owners to benefit from constrained high-quality supply.
  • Operational and property upgrades: Redevelopments and capex that improve unit economics (appeal to higher acuity needs, better clinical workflow, better patient experience) can support longer-term rent stability and occupancy.

Over a 5–10 year horizon, total addressable market expansion is supported by both population-driven demand and the need to modernize aging healthcare facilities, which can translate into improved long-run cash flow durability.

⚠ Risk Factors to Monitor

  • Operator and occupancy risk: Senior housing performance can be influenced by operator execution, staffing availability, and resident demand; lease economics can amplify downside during stress periods.
  • Regulatory and reimbursement changes: Changes to reimbursement frameworks and compliance requirements can affect operator profitability and renewal/capital expectations.
  • Interest rate and refinancing risk: REITs are sensitive to cost of capital; higher rates can pressure AFFO growth through increased debt service and higher capitalisation rates.
  • Capital intensity and execution risk: Redevelopment and modernization require timely execution and disciplined project economics to avoid value leakage.
  • Concentration and lease term structure: Tenant concentration, lease expiries, and “workout” dynamics can create variability in cash flow realization.

📊 Valuation & Market View

The market typically values healthcare REITs using cash-flow and asset-quality frameworks, often anchored to AFFO/FFO-derived measures and property-level NOI growth, rather than earnings-driven valuation alone. Key inputs that move valuation in this sector include:

  • Growth and visibility in same-store NOI/AFFO (occupancy, rent escalators, expense control)
  • Quality of lease structures and resilience of operator counterparties
  • Capitalisation rates / cost of debt (driving redevelopment economics and refinancing outcomes)
  • Balance sheet leverage and liquidity profile

Investors generally assign a premium to portfolios that demonstrate steadier long-term cash conversion, disciplined capital deployment, and strong operator/asset underwriting—attributes that reduce probability-weighted downside.

🔍 Investment Takeaway

Ventas’ long-term thesis rests on durable healthcare real estate demand, the practical switching costs inherent in healthcare facility operations, and the company’s ability to underwrite and manage assets in an operationally and regulatorily complex domain. The core bet is that Ventas can sustain resilient cash flows through disciplined capital allocation and tenant selection, while leveraging its healthcare-focused platform to navigate industry cyclicality and interest-rate volatility.


⚠ AI-generated — informational only. Validate using filings before investing.

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for VTR.

zacks.com2026-06-12

Why Ventas (VTR) is a Great Dividend Stock Right Now

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Ventas (VTR) have what it takes?

benzinga.com2026-06-09

Top 3 Real Estate Stocks Which Could Rescue Your Portfolio In June

The most oversold stocks in the real estate sector presents an opportunity to buy into undervalued companies.

businesswire.com2026-06-03

Ventas Chairman and CEO Debra A. Cafaro to Receive Cyrus McCormick Making History Award for Historic Corporate Achievement

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) today announced that Chairman and Chief Executive Officer Debra A. Cafaro will receive the Cyrus McCormick Making History Award for Historic Corporate Achievement at the Chicago History Museum's 32nd Annual Making History Awards this evening. The Cyrus McCormick Making History Award for Historic Corporate Achievement recognizes business leaders and organizations whose work has made enduring contributions to Chicago's economic and civic life. Un.

businesswire.com2026-06-01

Ventas Issues Business Update and Will Participate in Investor Meetings at Nareit's REITweek 2026 Investor Conference

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today announced that it has issued an investor presentation, which is available on the Company's website at ir.ventasreit.com/events-and-presentations. Company management will participate in investor meetings at Nareit's REITweek 2026 Investor Conference. About Ventas Ventas, Inc. (NYSE: VTR) is an S&P 500 company enabling exceptional environments that benefit a large and growing aging population. With more than.

seekingalpha.com2026-06-01

The Smart Money Is Quietly Buying These REITs

Smart money is piling into data centers and senior housing. One top activist REIT investor is making contrarian bets. INVH and NHI could be overlooked beneficiaries.

benzinga.com2026-05-28

Ford, Ventas, QXO And More On CNBC's 'Final Trades'

On CNBC's “Halftime Report Final Trades,” Joseph Terranova, senior managing director, Virtus Investment Partners, recommended Ford Motor Company (NYSE:F).

seekingalpha.com2026-05-28

U.S. REIT At-The-Market Activity Dips In Q1 2026

Thirty-three US REITs utilized their at-the-market (ATM) offering programs during the recent quarter, raising $4.15 billion in aggregate proceeds. Healthcare REIT Welltower Inc. raised the most capital during the first quarter, selling nearly 7.7 million shares of common stock through its ATM program for $1.56 billion in gross proceeds. In the aggregate, healthcare REITs raised $2.67 billion through their ATM programs during the first quarter, the most of any property sector. The data center REIT sector was next with $875.0 million.

zacks.com2026-05-27

Why Ventas (VTR) is a Top Dividend Stock for Your Portfolio

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Ventas (VTR) have what it takes?

seekingalpha.com2026-05-16

The REIT Repricing Cycle Is Nearing A Turning Point

REITs may be emerging from a brutal multi-year downturn. Falling supply and stabilizing rates could drive recovery. Valuations and buyouts signal strong upside ahead.

businesswire.com2026-05-13

Ventas Declares Quarterly Dividend of $0.52 Per Common Share

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) today announced that its Board of Directors has declared a quarterly dividend of $0.52 per common share. The dividend will be payable in cash on July 16, 2026, to stockholders of record as of the close of business on June 30, 2026. About Ventas Ventas, Inc. (NYSE: VTR) is an S&P 500 company enabling exceptional environments that benefit a large and growing aging population. With more than 1,400 properties in North America and the United Kin.

zacks.com2026-05-11

Ventas (VTR) Could Be a Great Choice

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Ventas (VTR) have what it takes?

seekingalpha.com2026-05-03

REITs Excel, Earnings Swell, Fed Rebels

U.S. equity markets advanced for a fifth straight week - their longest winning streak since 2024 - as strong earnings, resilient data, and hopes for lasting Iran peace fueled optimism. Investors looked through another oil-price surge and inflationary pressure, focusing instead on corporate resilience and economic strength despite a complex macro backdrop shaped by geopolitical and policy uncertainty. The Fed held rates steady in an unusually fractured 8-4 vote, while Powell's plan to remain on the Board broke precedent and raised politically charged succession questions.

zacks.com2026-04-29

Welltower's Q1 FFO Beat Estimates on Strong SHO NOI Growth

WELL tops Q1 FFO estimates as SHO NOI surges, occupancy improves and 2026 guidance increases on strong operating leverage.

seekingalpha.com2026-04-28

Ventas, Inc. (VTR) Q1 2026 Earnings Call Transcript

Ventas, Inc. (VTR) Q1 2026 Earnings Call Transcript

zacks.com2026-04-28

Ventas Q1 FFO & Revenues Beat Estimates on Strong SHOP Results

VTR posts Q1 FFO and revenue growth as senior housing demand lifted SHOP results, prompting higher 2026 guidance and a bigger investment plan.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"VTR reported Q1 2026 results with Revenue of $1.66B and Net Income of $55.9M (EPS $0.12). On a YoY basis, Revenue rose from $1.36B in Q1 2025 to $1.66B in Q1 2026 (+22.0%), and Net Income increased from $46.9M to $55.9M (+19.2%). QoQ, Revenue grew from $1.57B in Q4 2025 to $1.66B (+5.8%), while Net Income declined from $70.2M to $55.9M (-20.4%). Profitability was broadly resilient: gross margin was ~39.6% in Q1 2026 versus ~42.1% in Q1 2025 (mild contraction over the year). Operating margin slipped QoQ (11.6% vs 13.0% in Q4 2025) but was still within the recent quarterly range. Cash flow quality looks solid for a REIT-like profile: operating cash flow was $394.6M and free cash flow was $321.6M in the quarter. Balance sheet resilience improved in the period: cash jumped to $183.6M and net debt turned to negative (-$183.6M) versus positive net debt in prior quarters (driven by changes in cash/debt presentation). Shareholder returns were strong given price momentum (1y_change +25.83%) alongside a modest dividend yield (~0.59%). Buybacks were not reported in Q1 2026, and no dividends were paid in the quarter per the cash flow line item."

Revenue Growth

Strong

Revenue grew +22.0% YoY (Q1 2025 $1.36B to Q1 2026 $1.66B) and +5.8% QoQ (Q4 2025 $1.57B to Q1 2026 $1.66B), indicating an improving top line despite some volatility in earnings.

Profitability

Positive

Net Income rose +19.2% YoY ($46.9M to $55.9M) but fell -20.4% QoQ ($70.2M to $55.9M). Margins eased over the year (gross margin ~39.6% vs ~42.1% in Q1 2025) and contracted QoQ (operating margin 11.6% vs 13.0% in Q4 2025).

Cash Flow Quality

Good

Operating cash flow was $394.6M with free cash flow of $321.6M in Q1 2026. Dividend paid was reported as $0 in the quarter cash flow line item, while prior quarters showed sizable dividend payments; buybacks were not reported in Q1 2026.

Leverage & Balance Sheet

Good

Balance sheet position appears to have strengthened in Q1 2026: cash rose to $183.6M and net debt turned negative (-$183.6M) versus net debt levels over $12B in prior quarters, indicating improved liquidity/resilience in the latest reported period.

Shareholder Returns

Strong

Strong capital appreciation momentum: price 1y_change is +25.83% and 6m_change +22.36%. Dividend yield is modest (~0.59%) and cash-flow dividends were not recorded as paid in Q1 2026, but total return momentum remains supportive.

Analyst Sentiment & Valuation

Fair

With the stock price near $85.1 and consensus target around $90.33, upside to the mean target is limited (~6%). Valuation metrics in the provided ratios indicate high implied multiples, which tempers the score despite positive earnings trends.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

Ventas delivered a strong Q1 anchored by SHOP durability: same-store NOI growth over 15% YoY, U.S. occupancy +370 bps to 90.4%, and NOI margin expansion of 170 bps to 30%. Management also demonstrated operational scalability through Ventas OI—sales culture, price-volume optimization, and boots-on-the-ground execution—aiming for “zero lost revenue days.” The quarter translated into a higher 2026 outlook: normalized FFO per share midpoint up $0.03 to $3.86, with SHOP same-store NOI guidance lifted to 16% (and occupancy growth expected around +300 bps). External growth strengthened as well—$1.7B invested YTD and $540M Revel acquisition under a Ventas OI playbook—prompting an increased 2026 investment volume target to $3B. Key watch items are execution during the May–September selling season and whether competition/cap-rate compression persists, though cap rates are guided to remain in the high-6s.

AI IconGrowth Catalysts

  • SHOP same-store property NOI increased over 15% YoY for 5th consecutive year of double-digit NOI growth
  • U.S. SHOP same-store occupancy increased 370 bps YoY to support NOI growth
  • Ventro OI initiatives driving operating leverage: sales culture focus and “zero lost revenue days” goal
  • Increased full-year SHOP outlook: same-store NOI growth guidance to 16% at midpoint (from 15%)
  • Accretive senior housing investment activity contributing to total-company same-store NOI growth (nearly 9%)

Business Development

  • Revel portfolio acquisition (~$540 million) created a value-add lease-up opportunity; seller (Wolff/Revel) retained 25% interest to share in Ventas OI upside
  • Revel deal sourced off-market and tied to Ventas OI deployment under an ongoing joint venture structure
  • Brookdale triple-net cash rent escalator (35%) went into effect 01/01/2026, supporting OMAR and triple-net NOI performance
  • Ventas OI managing network expanded to 44 operators (mentioned in Q&A as a platform capability)

AI IconFinancial Highlights

  • Normalized FFO per share: $0.94 in Q1 2026 (up 9% YoY); total company same-store property-level cash NOI nearly 9%
  • SHOP same-store NOI: over 15% YoY; NOI margins expanded 170 bps YoY to 30%; incremental margins at ~50% with unit/community growth
  • U.S. SHOP occupancy: +370 bps YoY to 90.4%; overall same-store average occupancy +310 bps YoY to 90.4%
  • Full-year normalized FFO per share midpoint raised by $0.03 to $3.86 (range $3.82–$3.89)
  • Guidance bridge for $0.03: +$0.04 from stronger organic property performance (SHOP) and accretive senior housing investments; -$0.01 from higher forward interest rate curve
  • Total company same-store cash NOI growth outlook increased to nearly 10% at midpoint, driven by a 100 bps higher SHOP midpoint (to 16%)
  • OMAR same-store cash NOI: +2.4% YoY; outpatient medical +3.1% YoY; outpatient occupancy nearly 91% (+50 bps YoY for 7 consecutive quarters
  • Operating expenses: +5.8% YoY in Q1, described as largely weather-related; full-year OpEx guide 5.5% includes weather/volume effects

AI IconCapital Funding

  • Liquidity: $5.5 billion available at Q1 end (record levels referenced in prepared remarks)
  • Raised ~$2.4 billion of equity designated for 2026 investment activity: $800 million settled in Q1 plus $1.6 billion available through forward equity sale agreements
  • Net debt to EBITDA: 5.0x at quarter end; improved 20 bps sequentially; further improvement expected through the year
  • No explicit buyback authorization/amount disclosed in the provided transcript

AI IconStrategy & Ops

  • Ventas OI roll-out emphasized: refresh CapEx, price-volume optimization guidance, and sales culture initiatives; boots-on-the-ground site visits
  • Operational objective: “zero lost revenue days” in highly occupied communities
  • Focus on occupancy as primary driver of revenue growth; U.S. communities average ~87% occupancy cited (still runway vs 90%+ behavior)
  • 2026 investment allocation: highest priority U.S. SHOP acquisitions meeting framework and targeting unlevered IRRs in the double-digit to mid-teens with pricing below replacement cost
  • Development stance: despite strong demand outlook, construction starts cited as only ~1,500 new units in Q1 2026; Ventas stated development is not current focus

AI IconMarket Outlook

  • 2026 senior housing investment volume guidance increased to $3 billion (from $2.5 billion)
  • 2026 SHOP same-store NOI growth outlook increased to 16% at midpoint (from 15%)
  • Guidance for SHOP occupancy growth expectation: approximately 300 bps for the full year; revenue growth expectation ~8.75%
  • Key selling season timing: May–September; management emphasized season outcome will determine full-year performance
  • Cap rate expectations in remainder of year: “high-6s moving forward” (after drift from 7s to 6s earlier)

AI IconRisks & Headwinds

  • Weather-related cost impact: Q1 operating expenses +5.8% YoY driven largely by winter storm-related costs (may normalize later)
  • Execution risk around the May–September key selling season; management stated full-year outcome depends on performance during the season
  • Cap rate compression/competition: increasing interest from new investors (PE, owner-operators, other REITs, institutional capital); cap rates drifted down to ~6s
  • Development supply remains constrained by rent/investment underwriting gap: most developments require 20%–40% higher rents to pencil (not near-term supply response)
  • Recycling/disposition is limited and targeted: management indicated annual targeted dispositions typically a few hundred million dollars

Q&A: Analyst Interest

  • Revel investment performance drivers and Ventas OI levers: Management attributed Revel’s mid-70% occupancy primarily to lease-up/partially stabilized newer product rather than structural product mismatch. They cited immediate sales upside on the ground and targeted actions via Ventas OI analytics plus pricing sophistication to improve sales execution and occupancy trajectory.
  • Competition, cap rates, and deal environment: Management said competition is increasing with new investor entrants, but they raised guidance with confidence due to Ventas OI moat. They referenced relationship-driven sourcing (90% relationship, 60% off-market, 40% repeat sellers) and guided cap rates to high-6s for the remainder of the year.
  • Costs, incremental margins, and seasonality: Analysts asked how OpEx composition and incremental margin could evolve as occupancy rises. Management said Q1 OpEx was largely weather-related within a 5.5% full-year guide and incremental margins assume remaining in the 50s; 90%+ communities historically reach ~70% incremental margin.

Sentiment: POSITIVE

Note: This summary was synthesized by AI from the VTR Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

📋 Official Regulatory 10-K / 10-Q SEC Filings

Direct authenticated documentation links to audited SEC database reports for VTR.

SEC EDGAR Live Feed
Loading financial data and tables...
📁

SEC Filings (VTR)

© 2026 Stock Market Info — Ventas, Inc. (VTR) Financial Profile